Skip to main content
. 2017 Apr 4;47(12):2081–2096. doi: 10.1017/S0033291717000526

Table:

Outcome measure scores at pre-test and four post-tests for three study groups in three countries (N = 265)

MBPEG (n = 111) CPEG (n = 110) TAU (n = 112)
Hong Kong China Taiwan Hong Kong China Taiwan Hong Kong China Taiwan
Instrument M ± s.d. M ± s.d. M ± s.d. M ± s.d. M ± s.d. M ± s.d. M ± s.d. M ± s.d. M ± s.d.
ITAQ (0–22)a
Time 1 9.3 ± 3.0 9.4 ± 3.1 9.2 ± 3.0 9.3 ± 3.5 9.1 ± 3.4 9.5 ± 3.7 9.3 ± 4.0 9.2 ± 3.9 9.2 ± 4.0
Time 2 10.3 ± 4.4 10.5 ± 4.2 10.2 ± 4.9 9.2 ± 4.6 9.5 ± 3.9 9.1 ± 3.5 9.1 ± 5.0 9.0 ± 4.0 9.2 ± 4.1
Time 3 13.7 ± 5.0 13.6 ± 5.4 13.8 ± 5.9 10.3 ± 5.3 10.2 ± 5.0 10.6 ± 5.8 9.7 ± 5.1 9.8 ± 5.0 9.7 ± 4.3
Time 4 14.1 ± 6.0 14.4 ± 6.9 14.0 ± 6.5 9.9 ± 6.0 9.8 ± 5.1 10.0 ± 5.9 9.1 ± 4.0 8.9 ± 3.7 9.2 ± 3.9
Time 5 17.7 ± 5.3 17.9 ± 5.8 17.5 ± 6.5 10.2 ± 6.0 10.4 ± 6.1 10.2 ± 6.7 8.8 ± 2.9 9.0 ± 3.0 9.1 ± 4.0
SLOF (43–215)
Time 1 139.0 ± 17.1 139.1 ± 15.8 138.9 ± 17.0 137.5 ± 18.2 137.8 ± 17.4 138.2 ± 18.1 138.7 ± 16.2 138.6 ± 16.5 138.9 ± 16.2
Time 2 158.8 ± 17.0 159.1 ± 15.8 159.1 ± 14.9 143.6 ± 16.9 143.9 ± 17.8 143.8 ± 19.0 136.5 ± 16.4 136.7 ± 17.2 136.3 ± 18.1
Time 3 168.8 ± 19.8 169.1 ± 16.8 169.8 ± 18.9 146.7 ± 19.6 146.1 ± 20.0 146.8 ± 20.2 134.7 ± 17.9 134.6 ± 18.0 135.0 ± 18.2
Time 4 178.1 ± 19.8 179.1 ± 19.0 179.5 ± 17.0 149.5 ± 20.9 149.7 ± 21.0 150.3 ± 22.0 130.1 ± 18.4 130.7 ± 18.0 131.0 ± 19.2
Time 5 198.8 ± 19.8 198.0 ± 20.1 198.3 ± 20.3 156.2 ± 18.9 156.5 ± 21.2 156.0 ± 22.0 132.0 ± 18.1 131.8 ± 19.8 132.4 ± 19.1
PANSS (30–210)
Time 1 80.2 ± 10.2 80.1 ± 10.0 80.5 ± 11.2 80.8 ± 8.6 81.2 ± 8.1 81.4 ± 8.8 80.9 ± 9.1 81.3 ± 9.0 81.0 ± 8.9
Time 2 74.6 ± 9.1 74.7 ± 8.8 74.9 ± 9.3 82.0 ± 8.9 82.4 ± 9.0 82.3 ± 9.2 80.8 ± 8.9 81.2 ± 9.0 81.0 ± 8.1
Time 3 71.0 ± 9.9 70.9 ± 10.1 71.3 ± 11.2 80.6 ± 8.1 80.9 ± 9.0 81.2 ± 9.2 85.6 ± 10.0 85.9 ± 10.2 85.4 ± 8.8
Time 4 69.7 ± 9.6 70.0 ± 9.7 70.3 ± 9.8 79.2 ± 10.0 78.6 ± 9.8 79.3 ± 9.5 89.3 ± 12.0 89.1 ± 11.8 88.7 ± 10.7
Time 5 64.2 ± 8.2 64.5 ± 8.8 64.6 ± 9.0 76.4 ± 9.0 76.3 ± 9.5 76.8 ± 9.8 89.7 ± 13.9 89.9 ± 13.1 90.0 ± 14.1
SSQ6 (0–30)
Time 1 6.7 ± 2.0 6.7 ± 2.1 6.9 ± 2.2 7.0 ± 2.2 7.0 ± 2.3 7.4 ± 2.4 6.9 ± 2.6 7.1 ± 2.8 7.2 ± 2.9
Time 2 7.0 ± 2.0 6.7 ± 2.0 6.8 ± 2.1 7.0 ± 2.3 7.1 ± 2.9 7.4 ± 3.0 6.8 ± 2.9 7.0 ± 3.0 6.8 ± 3.2
Time 3 6.4 ± 2.5 6.6 ± 2.1 6.7 ± 2.5 6.7 ± 2.5 6.9 ± 2.3 7.0 ± 2.9 7.1 ± 3.4 7.2 ± 3.0 6.9 ± 3.0
Time 4 6.8 ± 2.4 6.7 ± 2.3 6.9 ± 2.8 7.0 ± 2.6 7.0 ± 2.5 7.1 ± 2.8 6.5 ± 3.0 6.9 ± 3.1 6.8 ± 3.0
Time 5 7.2 ± 2.4 7.1 ± 2.2 7.4 ± 2.3 7.1 ± 2.9 6.8 ± 3.0 6.8 ± 3.0 6.4 ± 2.2 6.7 ± 2.0 6.8 ± 2.9
Re-hospitalizations
Average Numberb
Time 1 2.8 ± 1.9 2.9 ± 2.0 2.8 ± 3.0 3.1 ± 2.1 2.9 ± 2.1 2.9 ± 2.0 3.1 ± 1.8 3.0 ± 1.9 2.9 ± 2.0
Time 2 2.4 ± 1.9 2.6 ± 2.0 2.5 ± 2.4 2.9 ± 1.8 3.0 ± 2.2 2.8 ± 2.0 2.8 ± 1.5 2.6 ± 1.9 2.8 ± 1.9
Time 3 2.2 ± 2.1 2.4 ± 2.1 2.5 ± 2.1 2.8 ± 2.1 2.6 ± 3.0 2.7 ± 2.5 2.7 ± 2.0 2.8 ± 2.0 2.6 ± 2.0
Time 4 2.1 ± 1.9 2.3 ± 2.0 2.3 ± 2.0 2.8 ± 2.0 2.7 ± 2.1 2.9 ± 2.3 3.1 ± 2.5 2.9 ± 2.8 2.8 ± 2.2
Time 5 1.8 ± 1.5 2.0 ± 1.6 2.0 ± 1.7 2.6 ± 1.9 2.8 ± 2.0 2.7 ± 2.3 2.9 ± 2.2 2.7 ± 2.7 2.6 ± 2.0
Durationc
Time 1 19.1 ± 8.0 19.3 ± 9.0 19.0 ± 9.1 18.8 ± 8.1 19.0 ± 8.8 19.0 ± 8.1 19.1 ± 9.0 19.4 ± 8.8 19.5 ± 9.2
Time 2 15.4 ± 5.5 15.8 ± 6.0 16.0 ± 8.2 17.6 ± 9.0 17.8 ± 9.0 17.8 ± 9.0 21.7 ± 10.0 21.7 ± 9.8 21.0 ± 10.0
Time 3 12.9 ± 6.9 13.5 ± 7.0 13.5 ± 7.1 16.3 ± 9.0 16.4 ± 10.0 16.1 ± 9.8 20.3 ± 10.0 20.4 ± 10.1 20.4 ± 9.0
Time 4 11.9 ± 6.9 12.2 ± 7.8 12.0 ± 7.0 17.3 ± 9.1 17.3 ± 9.0 17.7 ± 9.2 20.8 ± 9.8 20.9 ± 10.0 21.2 ± 10.5
Time 5 10.0 ± 7.1 10.3 ± 7.0 10.4 ± 7.8 16.2 ± 9.1 16.3 ± 9.3 16.0 ± 9.1 21.5 ± 13.0 21.9 ± 10.2 21.5 ± 10.2

MBPEG, Mindfulness-based psycho-education group; CPEG, conventional psycho-education group; TAU, treatment-as-usual; time 1, baseline measurement at the start of intervention; time 2, one-week post-intervention; time 3, 6 months post-intervention; time 4, 12 months post-intervention; time 5, 24 months post-intervention; ITAQ, Insight and Treatment Attitudes Questionnaire; PANSS, Positive and Negative Syndrome Scale; SSQ6, Six-item Social Support Questionnaire; SLOF, Specific Level of Functioning Scale.

a

Possible range of scores of each scale indicated in parenthesis.

b

Average number of readmissions to a psychiatric in-patient unit over the previous 6–12 months at the five measurements (times 1 to 5).

c

Duration/length of readmissions to a psychiatric in-patient ward/unit in terms of average number of days of hospital stay over the previous 6 months at times 1 to 5.